Skip to main content

Advertisement

Table 2 Final diagnostic distribution after the 18 months follow up period.

From: Plasmatic level of neurosin predicts outcome of mild cognitive impairment

  >5.25 ≤ 5.25 P (χ2 test)
MCI 12 (40%) 18 (60%) 0.437
AD 7 (30%) 16 (70%) 0.004
DVasc.Comp 12 (93%) 1 (7%) <0.001
  1. Patients initially diagnosed with MCI were followed up for 18 months. Data show final diagnostic distribution in relation to their initial plasmatic levels of neurosin (≤ or > 5.25 ng/ml) and the association (p) value.